CelLBxHealth plc

CelLBxHealth plc

0.01
USD
-0.01
(-50.75%)
19.54MMarket Cap
Apr 29Next Earn

Total Valuation

USD

As of December 31, 2025, CELLBXHEALTH PLC carries a market capitalization of 19.54M, placing it among publicly traded companies globally. Its enterprise value stands at 12.09M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap19.54M
Enterprise Value12.09M

Important Dates

CELLBXHEALTH PLC 's next confirmed earnings release is scheduled for April 29, 2027.

Earnings Date4/29/2027

Share Statistics

As of December 31, 2025, CELLBXHEALTH PLC has 1.14B shares outstanding.

Shares Outstanding1.14B

Valuation Ratios

These figures are as of December 31, 2025.

PB Ratio2.02
P/TBV Ratio2.13

Financial Position

As of December 31, 2025, CELLBXHEALTH PLC maintains a current ratio of 2.76, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

Current Ratio2.76
Quick Ratio1.95
Debt / Equity25.25

Financial Efficiency

These figures cover the twelve months ended December 31, 2025.

Employee Count81.50

Stock Price Statistics

As of the close on October 22, 2026, CELLBXHEALTH PLC 's stock has declined approximately 60.80% over the past 52 weeks.

52-Week Price Change-60.80%

Balance Sheet

USD

As of December 31, 2025, CELLBXHEALTH PLC holds 9.90M in cash and equivalents against 2.45M in total debt, resulting in a net debt position of -9.90M. Total book value stands at 9.70M, with working capital of 8.92M providing operational flexibility.

Cash & Cash Equivalents9.90M
Total Debt2.45M
Net Debt-9.90M
Equity (Book Value)9.70M
Book Value Per Share0.01
Working Capital8.92M

Stock Splits

CELLBXHEALTH PLC 's most recent stock split took place on June 6, 2024.

Last Split Date6/6/2024